Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of January 2023, with the report dated January 23, 2023. The filing serves to disclose a significant corporate development regarding intellectual property rather than providing periodic financial results.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material change disclosed is the receipt of a Notice of Allowance from the U.S. Patent Office for a novel cryogenic pump designed for next-generation cryoablation systems. This represents a milestone in the company's product development and intellectual property portfolio.
Guidance, Outlook, and Risks
The filing incorporates by reference the "Forward-Looking Statements" section from the accompanying press release (Exhibit 99.1). The text does not explicitly detail specific financial guidance, management commentary on future performance, or a list of risks within the body of this Form 6-K, deferring to the referenced press release for such disclosures.
Investor Verification Checklist
- Verify the specific claims and scope of the granted patent for the novel cryogenic pump in Exhibit 99.1.
- Review the "Forward-Looking Statements" in the press release to understand potential risks associated with commercializing the new technology.
- Confirm the timeline for the integration of this new pump into next-generation cryoablation systems.
- Check subsequent filings for any updates on the patent issuance or related regulatory approvals.